Health Care Reform and the Role of Medical Technologies: Hearing Before the Subcommittee on Technology, Environment, and Aviation of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, First Session, June 16, 1993, 4. sējumsU.S. Government Printing Office, 1993 - 103 lappuses |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
Administration American Association June 16 billion biotechnology cancer Chairman cholecystectomy clinical companies Computer COPPERSMITH cost of health coverage CSPP recommends demonstration projects diagnostic imaging disease drug benefit economic Edward example Glaxo going health care costs health care reform health care system Health Industry Manufacturers healthcare information infrastructure HIMA hospital stays imaging equipment imaging technologies improve increase Industry Manufacturers Association information appliances information technology investment issue Japan KOHRT LEWIS LINDER major Manufacturers Association June market forces MCHALE medical devices medical technology industry Medicare medicines MOSSINGHOFF NAFTA Niedel outcomes research patient records percent pharmaceutical industry physicians policies price controls problems procedure programs question reduce costs reimbursement Rozynski Health Industry SAM COPPERSMITH sector Subcommittee surgery technology assessment telemedicine teleradiology Thank therapy there's TIM VALENTINE treatment U.S. industries U.S. medical technology United VALENTINE Whitaker Foundation
Populāri fragmenti
83. lappuse - The National Science Foundation (NSF) is an independent agency of the Federal Government established in 1950 to promote and advance scientific progress in the United States.
34. lappuse - Mr. Chairman, that concludes my prepared Statement. I would be pleased to respond to any question that you or Members of the Subcommittee may have.
13. lappuse - Less Than the Sum of Its Parts: Reforms Needed in the Organization, Management, and Resources of the Food and Drug Administration's Center for Devices and Radiological Health,' and issued in May 1993, presented a seven critique of the Center and its regulatory activities.
17. lappuse - US health care system is $125.6 billion - or 17 percent of total health expenditures. The Health Care Financing Administration (HCFA) projects that the automation and aggregation of clinical data alone could save nearly $18 billion in 1993 by reducing the incidence of diagnostic tests, reducing length of stay, making hospital staff more efficient, and improving the overall quality of care. Aside from claims financing and standardization, HCFA estimates total savings for the following categories...
32. lappuse - Pharmaceutical R&D is an investment, and the principal characteristic of an investment is that money is spent today in the hopes of generating even more money in the future. Pharmaceutical R&D is a risky investment; therefore, high financial returns are necessary to induce companies to invest in researching new chemical entities.
51. lappuse - Sunshine JH, Mabry MR, Bansal S. The volume and cost of radiologic services in the United States in 1990.
17. lappuse - Administration (HCFA) projects that the automation and aggregation of clinical data alone could save nearly $18 billion in 1993 by reducing the incidence of diagnostic tests, reducing length of stay, making hospital staff more efficient, and improving the overall quality of care. Aside from claims financing and standardization, HCFA estimates total savings for the following categories: $82 million for automation of claims inquiries; $439 million for automation of enrollment and eligibility functions;...
33. lappuse - On Wall Street, stock prices of blotech companies have plummeted. Financing has dried up. And plans for expansion. Including hiring, new construction and new proj ects , have been put on hold...
14. lappuse - A great deal has been written, most of it misinformed, about how technology drives up health care costs. Let me address that point, briefly. It is important, first of all, to distinguish between the purchase price of technology - that is, what it costs a provider to buy a medical device - and the...
14. lappuse - We think it is critical that our nation provide access to a basic health care package for all citizens. We must also reduce the costs of that care in ways that do not diminish the high quality that makes US health care the best in the world. We believe that we can build on what works in our health care system by making it more competitive. We support...